title: Lactate production by thrombin-activated platelets of patients with primary thrombocythemia.
abstract: BACKGROUND
  Platelet activation needs a high energy demand which is supplied by the degradation of glucose into lactate. Platelet response to agonists in patients with primary thrombocythemia is defective. We studied the production of lactate by the platelets of patients with this disease and defective platelet aggregation.
  
  
  METHODS
  Ten patients suffering from primary thrombocythemia and ten controls were included in this study. The lactate generation was measured in resting and thrombin activated platelets in absence or presence of glucose.
  
  
  RESULTS
  Resting platelets incubated for 30 min in phosphate-buffered saline (PBS) generated the same amount of lactate in patients (44.6+/-21.6 micromol/10(11) cells) and controls (41.0+/-17.3 micromol/10(11) cells). Addition of glucose led to similar increases in lactate formation by platelets in patients (82.2+/-26.4 micromol/10(11) cells) and controls (88.1+/-34.5 micromol/10(11) cells). The addition of thrombin in absence of glucose did not modify the lactate formation respective to PBS. Finally, the incubation of platelets with both glucose and thrombin caused further increases in the generation of lactate in both groups, patients (236.9+/-83.9 micromol/10(11) cells) and controls (228.6+/-63.5 micromol/10(11) cells) without differences between them. The production of lactate in both groups was also similar when platelets were incubated for 10 min or 20 min with both thrombin and glucose. However at 5 min, platelets of patients generated more lactate (97.8+/-23.7 micromol/10(11) cells) than controls (66.5+/-38.7 micromol/10(11) cells, p<0.05).
  
  
  CONCLUSIONS
  These results suggest that thrombin is able to induce an initial hyperactivity of those pathways involved in the platelet energy production of patients with primary thrombocythemia.
authors.affiliation: Department of Haematology, Hospital Ramón y Cajal, Ctera Colmenar Km 9,1. 28034 Madrid, Spain. jcesar.hrc@salud.madrid
authors.forename: Jesús M
authors.initials: JM
authors.lastname: Cesar
authors.forename: Esperanza
authors.initials: E
authors.lastname: Pallares
authors.forename: José
authors.initials: J
authors.lastname: Rubí
authors.forename: José L
authors.initials: JL
authors.lastname: Navarro
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D019344:Lactic Acid / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D015539:Platelet Activation / Q000187:drug effects*; D013917:Thrombin / Q000494:pharmacology*; D013922:Thrombocytosis / Q000378:metabolism* / Q000473:pathology
chemical_list: D019344:Lactic Acid; D013917:Thrombin